A Phase II, Open Label Study of ONC201 in Adults with EGFR-low Glioblastoma
|Effective start/end date||7/2/21 → 12/28/22|
- Chimerix, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.